{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T15:07:40Z","timestamp":1767452860286},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00066-019-01550-6","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T17:02:37Z","timestamp":1575046957000},"page":"515-521","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Age-dependent hemato- and nephrotoxicity in patients with head and neck cancer receiving chemoradiotherapy with weekly cisplatin"],"prefix":"10.1007","volume":"196","author":[{"given":"Fabian","family":"Weykamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Seidensaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Rieken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Mende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Zaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kolja","family":"Freier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Adeberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan Ezechiel","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"1550_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner\u00a0JA, Harari\u00a0PM, Giralt\u00a0J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N\u00a0Engl J Med 354:567\u2013578","journal-title":"N Engl J Med"},{"key":"1550_CR2","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1002\/cncr.31708","volume":"124","author":"M Xiang","year":"2018","unstructured":"Xiang\u00a0M, Holsinger\u00a0FC, Colevas\u00a0AD, Chen\u00a0MM, Le\u00a0QT, Beadle\u00a0BM (2018) Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: a surveillance, epidemiology, and end results-medicare analysis. Cancer 124:4486\u20134494","journal-title":"Cancer"},{"key":"1550_CR3","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1200\/JCO.2018.36.15_suppl.6018","volume":"36","author":"XS Sun","year":"2018","unstructured":"Sun\u00a0XS, Sire\u00a0C, Tao\u00a0Y et al (2018) A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): first results of the GORTEC 2015-01 \u201cPembroRad\u201d trial. J\u00a0Clin Oncol 36:6018\u20136018","journal-title":"J. Clin. Oncol."},{"key":"1550_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/hed.24448","volume":"38","author":"Z Gooi","year":"2016","unstructured":"Gooi\u00a0Z, Fakhry\u00a0C, Goldenberg\u00a0D et\u00a0al (2016) AHNS Series: Do you know your guidelines?Principles of radiation therapy for head and neck cancer: a review of the National Comprehensive Cancer Network guidelines. Head Neck 38:987\u2013992","journal-title":"Head Neck"},{"key":"1550_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00066-018-1415-y","volume":"195","author":"Y Onbasi","year":"2019","unstructured":"Onbasi\u00a0Y, Lettmaier\u00a0S, Hecht\u00a0M et al (2019) Is there a\u00a0patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? Strahlenther Onkol 195:482\u2013495","journal-title":"Strahlenther Onkol"},{"key":"1550_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00066-018-1305-3","volume":"194","author":"S Tribius","year":"2018","unstructured":"Tribius\u00a0S, Meyer\u00a0MS, Pflug\u00a0C et\u00a0al (2018) Socioeconomic status and quality of life in patients with locally advanced head and neck cancer. Strahlenther Onkol 194:737\u2013749","journal-title":"Strahlenther Onkol"},{"key":"1550_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00066-018-1259-5","volume":"194","author":"C Nieder","year":"2018","unstructured":"Nieder\u00a0C, Kampe\u00a0TA, Pawinski\u00a0A, Dalhaug\u00a0A (2018) Patient-reported symptoms before palliative radiotherapy predict survival differences. Strahlenther Onkol 194:533\u2013538","journal-title":"Strahlenther Onkol"},{"key":"1550_CR8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00066-017-1206-x","volume":"193","author":"D Alterio","year":"2017","unstructured":"Alterio\u00a0D, Gerardi\u00a0MA, Cella\u00a0L et al (2017) Radiation-induced acute dysphagia: prospective observational study on 42 head and neck cancer patients. Strahlenther Onkol 193:971\u2013981","journal-title":"Strahlenther Onkol"},{"key":"1550_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00066-017-1146-5","volume":"193","author":"P Korner","year":"2017","unstructured":"Korner\u00a0P, Ehrmann\u00a0K, Hartmannsgruber\u00a0J et al (2017) Patient-reported symptoms during radiotherapy: clinically relevant symptom burden in patients treated with palliative and curative intent. Strahlenther Onkol 193:570\u2013577","journal-title":"Strahlenther Onkol"},{"key":"1550_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.radonc.2006.03.009","volume":"79","author":"V Gr\u00e9goire","year":"2006","unstructured":"Gr\u00e9goire\u00a0V, Eisbruch\u00a0A, Hamoir\u00a0M, Levendag\u00a0P (2006) Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 79:15\u201320","journal-title":"Radiother Oncol"},{"key":"1550_CR11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","volume":"69","author":"V Gr\u00e9goire","year":"2003","unstructured":"Gr\u00e9goire\u00a0V, Levendag\u00a0P, Ang\u00a0KK et al (2003) CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 69:227\u2013236","journal-title":"Radiother Oncol"},{"key":"1550_CR12","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.ijrobp.2009.04.095","volume":"76","author":"JP Kirkpatrick","year":"2010","unstructured":"Kirkpatrick\u00a0JP, van der Kogel\u00a0AJ, Schultheiss\u00a0TE (2010) Radiation dose\u2014volume effects in the spinal cord. Int J Radiat Oncol Biol Phys 76:S42\u2013S9","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1550_CR13","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","volume":"76","author":"C Mayo","year":"2010","unstructured":"Mayo\u00a0C, Martel\u00a0MK, Marks\u00a0LB, Flickinger\u00a0J, Nam\u00a0J, Kirkpatrick\u00a0J (2010) Radiation dose\u2014volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys 76:S28\u2013S35","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1550_CR14","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.ijrobp.2009.06.090","volume":"76","author":"JO Deasy","year":"2010","unstructured":"Deasy\u00a0JO, Moiseenko\u00a0V, Marks\u00a0L, Chao\u00a0KC, Nam\u00a0J, Eisbruch\u00a0A (2010) Radiotherapy dose\u2014volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 76:S58\u2013S63","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1550_CR15","doi-asserted-by":"publisher","DOI":"10.18356\/22e83351-en","volume-title":"World population ageing 2013","author":"U Nations","year":"2013","unstructured":"United Nations\u00a0(2013) World population ageing 2013. United Nations\u00a0Publ, New York, USA"},{"key":"1550_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1447-0594.2006.00341.x","volume":"6","author":"H Orimo","year":"2006","unstructured":"Orimo\u00a0H, Ito\u00a0H, Suzuki\u00a0T, Araki\u00a0A, Hosoi\u00a0T, Sawabe\u00a0M (2006) Reviewing the definition of \u201celderly\u201d. Geriatr Gerontol Int 6:149\u2013158","journal-title":"Geriatr Gerontol Int"},{"key":"1550_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.oraloncology.2018.12.028","volume":"89","author":"L Peng","year":"2019","unstructured":"Peng\u00a0L, Xu\u00a0C, Chen\u00a0Y\u2011P et al (2019) Optimizing the cumulative cisplatin dose during radiotherapy in nasopharyngeal carcinoma: dose-effect analysis for a\u00a0large cohort. Oral Oncol 89:102\u2013106","journal-title":"Oral Oncol"},{"key":"1550_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1743-7563.2011.01405.x","volume":"7","author":"Z Otty","year":"2011","unstructured":"Otty\u00a0Z, Skinner\u00a0MB, Dass\u00a0J et al (2011) Efficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients. Asia-Pac J Clin Oncol 7:287\u2013292","journal-title":"Asia-Pac J Clin Oncol"},{"key":"1550_CR19","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1200\/jco.2015.33.15_suppl.6020","volume":"33","author":"A Spreafico","year":"2015","unstructured":"Spreafico\u00a0A, Huang\u00a0SH, Xu\u00a0W et al (2015) Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (\u2212) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC). J\u00a0Clin Oncol 33:6020\u20136020","journal-title":"J. Clin. Oncol."},{"key":"1550_CR20","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1200\/JCO.2017.75.7161","volume":"36","author":"SS Motwani","year":"2018","unstructured":"Motwani\u00a0SS, McMahon\u00a0GM, Humphreys\u00a0BD, Partridge\u00a0AH, Waikar\u00a0SS, Curhan\u00a0GC (2018) Development and validation of a\u00a0risk prediction model for acute kidney injury after the first course of cisplatin. J\u00a0Clin Oncol 36:682\u2013688","journal-title":"J Clin Oncol"},{"key":"1550_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"J-P Pignon","year":"2009","unstructured":"Pignon\u00a0J\u2011P, Le Maitre\u00a0A, Maillard\u00a0E, Bourhis\u00a0J, Group M\u2011NC (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4\u201314","journal-title":"Radiother Oncol"},{"key":"1550_CR22","first-page":"62","volume":"45","author":"JM Melotek","year":"2016","unstructured":"Melotek\u00a0JM, Cooper\u00a0BT, Koshy\u00a0M, Silverman\u00a0JS, Spiotto\u00a0MT (2016) Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer. Head Neck Surg 45:62","journal-title":"Head Neck Surg"},{"key":"1550_CR23","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s00066-018-1283-5","volume":"194","author":"M Becker-Schiebe","year":"2018","unstructured":"Becker-Schiebe\u00a0M, Christiansen\u00a0H (2018) W\u00f6chentliche oder dreiw\u00f6chentliche Cisplatin-Gaben bei der kombinierten Radiochemotherapie lokal fortgeschrittener Kopf-Hals-Tumoren? Strahlenther Onkol 194:468\u2013470","journal-title":"Strahlenther Onkol"},{"key":"1550_CR24","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1002\/hed.25717","volume":"41","author":"RT Morse","year":"2019","unstructured":"Morse\u00a0RT, Ganju\u00a0RG, TenNapel\u00a0MJ et\u00a0al (2019) Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinoma. Head Neck 41:2492\u20132499","journal-title":"Head Neck"},{"key":"1550_CR25","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/hed.25379","volume":"41","author":"A Mohamed","year":"2019","unstructured":"Mohamed\u00a0A, Twardy\u00a0B, Zordok\u00a0MA et\u00a0al (2019) Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: comparative analysis. Head Neck 41:1490\u20131498","journal-title":"Head Neck"},{"key":"1550_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.oraloncology.2011.10.005","volume":"48","author":"V Espeli","year":"2012","unstructured":"Espeli\u00a0V, Zucca\u00a0E, Ghielmini\u00a0M et al (2012) Weekly and 3\u2011weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer. Oral Oncol 48:266\u2013271","journal-title":"Oral Oncol"},{"key":"1550_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/1748-717X-7-215","volume":"7","author":"D-L Tsan","year":"2012","unstructured":"Tsan\u00a0D\u2011L, Lin\u00a0C\u2011Y, Kang\u00a0C\u2011J et al (2012) The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity. Radiat Oncol 7:215","journal-title":"Radiat Oncol"},{"key":"1550_CR28","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1200\/JCO.2003.01.095","volume":"21","author":"PJ Hesketh","year":"2003","unstructured":"Hesketh\u00a0PJ, Grunberg\u00a0SM, Gralla\u00a0RJ et al (2003) The oral neurokinin\u20111 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a\u00a0multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin\u2014the Aprepitant Protocol 052 Study Group. J\u00a0Clin Oncol 21:4112\u20134119","journal-title":"J Clin Oncol"},{"key":"1550_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00520-017-3825-2","volume":"26","author":"J Herrstedt","year":"2018","unstructured":"Herrstedt\u00a0J, Summers\u00a0Y, Daugaard\u00a0G et al (2018) Amisulpride in the prevention of nausea and vomiting induced by cisplatin-based chemotherapy: a\u00a0dose-escalation study. Support Care Cancer 26:139\u2013145","journal-title":"Support Care Cancer"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01550-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-019-01550-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01550-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:04:52Z","timestamp":1606521892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-019-01550-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1550"],"URL":"https:\/\/doi.org\/10.1007\/s00066-019-01550-6","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"6 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.\u00a0Weykamp, K.\u00a0Seidensaal, S.\u00a0Rieken, K.\u00a0Green, S.\u00a0Mende, K.\u00a0Zaoui, K.\u00a0Freier, S.\u00a0Adeberg, J.\u00a0Debus, and S.E.\u00a0Welte declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}